天天综合天天做天天综合_国产综合日韩一区二区三区_91精品国自产在线播放_国产一级高清视频免费看

西紅花苷IV ,HPLC95%

Crocin IV
別名: 西紅花苷IV(分析標(biāo)準(zhǔn)品)
Cas號(hào): 57710-64-2 物化性質(zhì):
分子式: C32H44O14 熔點(diǎn):
分子量: 652.683371543884 沸點(diǎn):
EINECS編號(hào): 密度:
MDL號(hào): 儲(chǔ)存條件:

中文名稱(chēng)：西紅花苷IV
CAS號(hào)：57710-64-2
中文別名：西紅花苷IV(分析標(biāo)準(zhǔn)品)
英文名稱(chēng)：Crocin IV
分子式：C32H44O14
分子量：652.683371543884
用途：用于含量測(cè)定、鑒別、藥理實(shí)驗(yàn)、活性篩選等科研實(shí)驗(yàn)。如：細(xì)胞給藥、灌胃試驗(yàn)、藥廠內(nèi)部質(zhì)檢等。  
純度：≥98%  
分析方法:HPLC-DADor/andHPLC-ELSD（隨貨附帶質(zhì)檢報(bào)告和HPL圖譜）  
鑒定方法:質(zhì)譜（Mass）,核磁（NMR）  
包裝：棕色小玻璃瓶，標(biāo)準(zhǔn)包裝10mg,20mg,50mg,100mg,或根據(jù)客戶要求提供相應(yīng)包裝  
貯存：密封避光保存，2-8℃。  
有效期：2年  
質(zhì)量承諾：我公司產(chǎn)品長(zhǎng)期供應(yīng)各大科研機(jī)構(gòu)、藥廠、高校等，可先發(fā)貨后付款。本公司產(chǎn)品質(zhì)量問(wèn)題，我們?nèi)珯?quán)負(fù)責(zé)退貨換貨。  
請(qǐng)通過(guò)電話或QQ聯(lián)系客服人員，進(jìn)行產(chǎn)品訂購(gòu)和咨詢(xún)折扣情況！所有產(chǎn)品促銷(xiāo)中！ 
搜索質(zhì)檢報(bào)告(COA)
搜索MSDS
...

西紅花苷IV
1,1'-[(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate]-b-D-Glucopyranose;LogP;dicrocin;crocetin diglucosyl ester;Crocetin diglucopyranoside;bis(beta-D-glucosyl) crocetin;all-trans-crocetin di(beta-D-glucosyl) ester;8PF1UU481E;crocetin di(beta-D-glucopyranosyl) ester;trans-crocetin di(beta-D-glucosyl) ester;trans-Crocetin di-(beta-D-glucosyl) ester;beta-D-Glucopyranose, 1,1'-((2E;Crocin IV;TRANS-CROCETIN DI-(.BETA.-D-GLUCOSYL) ESTER;TRANS-CROCETIN DI-(.BETA.-D-GLUCOSYL) ESTER;CS-0159554;CS-0159554;Q27132162;Q27132162;57710-64-2;57710-64-2;MS-30971;MS-30971;bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;CHEBI:62768;CHEBI:62768;.BETA.-D-GLUCOPYRANOSE, 1,1'-((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-TETRAMETHYL-2,4,6,8,10,12,14-HEXADECAHEPTAENEDIOATE);.BETA.-D-GLUCOPYRANOSE, 1,1'-((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-TETRAMETHYL-2,4,6,8,10,12,14-HEXADECAHEPTAENEDIOATE);HY-N9371;HY-N9371;Bis((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;Bis((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;DTXSID001312682;DTXSID001312682;ALL-TRANS-CROCETIN DI(.BETA.-D-GLUCOSYL) ESTER;ALL-TRANS-CROCETIN DI(.BETA.-D-GLUCOSYL) ESTER;UNII-8PF1UU481E;UNII-8PF1UU481E;beta-D-Glucopyranose, 1,1'-((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate);beta-D-Glucopyranose, 1,1'-((2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate);C19868;C19868;bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate;crocetin di-(beta-d-glucosyl)-ester;crocetin di-(beta-d-glucosyl)-ester;crocetin di-(beta-delta-glucosyl)-ester;crocetin di-(beta-delta-glucosyl)-ester